NCT05669690

Brief Summary

Breast milk is the mainstay of newborn nutrition, providing all the nutrients and vitamins necessary for optimal growth of newborn infants. Beside its nutritional properties, breast milk also contains bioactive factors such as soluble immune factors, antimicrobial proteins, functional fatty acids, hormones, oligosaccharides, stem cells and microbiota. Although fresh breast milk is the optimal source of nutrition for newborn infants, breast milk must be expressed and stored in some conditions. Breast milk was thought to be sterile for many years. This idea has changed with the isolation of live bacteria in the breast milk of healthy mothers in the recent past. Thus, it has been shown that breast milk is not actually a sterile body fluid, but has a microbiota of its own. This study aimed to examine the effect of storage conditions of breast milk at different temperatures on the microbial composition of the breast milk. The prospective experimental study will be conducted under the supervision of Istanbul University, Istanbul Medical Faculty, Department of Pediatrics, Neonatology Department. Informed consent of mothers will be taken. Thirty mililiter (30 mL) breast milk that was obtained from volunteer mothers will be divided into 3 samples, each 10 mL of breast milk will be stored at different temperatures. Ten mililiter will be studied for microbial composition with 16S rRNA amplicon sequencing and bioinformatics analysis immediately, 10 mL will be stored at +4'C for 3 days and will be studied at the end of 3rd day, other 10 mL will be stored at -20'C for 3 months and will be studied at the end of 3rd months. 16S rRNA amplicon sequencing and bioinformatic analysis studies will be performed at Istanbul Medical Faculty Clinical Nutrition and Microbiota Research Laboratory. This present study is planned to be carried out for 24 months between January 2023 and December 2024

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 3, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

May 12, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2023

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2024

Completed
Last Updated

May 19, 2023

Status Verified

May 1, 2023

Enrollment Period

4 months

First QC Date

December 20, 2022

Last Update Submit

May 18, 2023

Conditions

Keywords

breast milkstorage conditionsmicrobiota

Outcome Measures

Primary Outcomes (1)

  • Changes in microbiota composition of breast milk after storage

    To evaluate the effects of different storage conditions on microbiota composition of breast milk

    24 months

Study Arms (3)

Fresh breast milk

Fresh breast milk obtained from volunteer mothers will be divided into four parts. Fresh breast milk will be studied for microbiota composition immediately within 3 hours.

Breast milk stored at +4'C for 3 days

One part of previously obtained fresh breast milk will be stored at +4'C at refrigerator for 3 days long, then microbiota composition will be studied.

Breast milk stored at -20'C for 3 months

Last part of the same breast milk specimen will be freezed at -20'C for 3 months and microbiota composition of the 3 months frozen milk will be studied.

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy young mothers who had vaginal delivery at least one week ago will be included

You may qualify if:

  • Women who had vaginal delivery
  • Women who gave delivery at gestational age above 37 weeks
  • Women who have a child older than 1 weeks of age
  • Mothers with a body mass index between 18.5-25
  • Women who gave consent

You may not qualify if:

  • Women who had cesarean delivery
  • Women who gave premature delivery (\<37 weeks of gestation)
  • Women who gave birth within prior 7 days
  • Women with premature rupture of membranes
  • Women with chorioamnionitis
  • Women who had antibiotherapy within last 1 week
  • Presence of mastitis
  • Presence of maternal co-morbid diseases such as; pregestational diabetes, pregestational hypertension, connective tissue diseases, inflammatory bowel syndrome, solid organ transplantation
  • Presence of evidenced congenital infections
  • Women who didn't give consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University Istanbul Medical Faculty

Istanbul, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Selma-Royo M, Calvo Lerma J, Cortes-Macias E, Collado MC. Human milk microbiome: From actual knowledge to future perspective. Semin Perinatol. 2021 Oct;45(6):151450. doi: 10.1016/j.semperi.2021.151450. Epub 2021 Jun 16.

    PMID: 34274151BACKGROUND
  • Pandya SP, Doshi H, Codipilly CN, Fireizen Y, Potak D, Schanler RJ. Bacterial stability with freezer storage of human milk. J Perinat Med. 2020 Sep 14;49(2):225-228. doi: 10.1515/jpm-2020-0131. Print 2021 Feb 23.

    PMID: 32915767BACKGROUND
  • Fernandez L, Ruiz L, Jara J, Orgaz B, Rodriguez JM. Strategies for the Preservation, Restoration and Modulation of the Human Milk Microbiota. Implications for Human Milk Banks and Neonatal Intensive Care Units. Front Microbiol. 2018 Nov 9;9:2676. doi: 10.3389/fmicb.2018.02676. eCollection 2018.

Biospecimen

Retention: SAMPLES WITH DNA

Breast milk

MeSH Terms

Conditions

Breast Milk ExpressionCommunicable Diseases

Condition Hierarchy (Ancestors)

Breast FeedingFeeding BehaviorBehaviorInfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Emine Asuman Coban, Professor

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Elmas Zeynep Ince, Professor

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Bülent Saka, Professor

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Leyla Bilgin, Professor

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Dilek Sever Kaya, Dr Biologist

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Aslı Berru Arslan, Med Student

    Istanbul University

    PRINCIPAL INVESTIGATOR
  • Beril Yasa, Ass. Prof.

    Istanbul University

    STUDY DIRECTOR

Central Study Contacts

Beril YASA, Ass. Prof.

CONTACT

Elmas Zeynep Ince, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 20, 2022

First Posted

January 3, 2023

Study Start

May 12, 2023

Primary Completion

September 15, 2023

Study Completion

December 14, 2024

Last Updated

May 19, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

It is planned to share individual participant data in terms of changes in microbiota composition of breast milk with different storage conditions. Special data about identity of participants will be kept blinded.

Shared Documents
CSR
Time Frame
Data about Clinical Study Report will become available after all samples are obtained, analyzed and study completed. The data will be available for 12 months period.
Access Criteria
The IPD will be uploaded to the registration system, any investigator will be able to access IPD

Locations